Is this the next breakthrough in tissue #TAVR? Congrats Chris Meduri, MD MPH vinayak bapat Susheel Kodali, MD Paul on DurAVR 1y data PCRonline 🫀 #PCR2023 EuroIntervention look fwd to EFS! MIЯVΛƬ #IC ༄ ｡° Isaac George MD Didier Tchetche David J. Cohen, MD, MSc thomas modine EduardoSaadi Tsuyoshi Kaneko

Dr. Gilbert Tang Chris Meduri, MD MPH vinayak bapat Susheel Kodali, MD Paul PCRonline 🫀 EuroIntervention MIЯVΛƬ #IC ༄ ｡° Isaac George MD Didier Tchetche David J. Cohen, MD, MSc thomas modine EduardoSaadi Tsuyoshi Kaneko More details here: m.youtube.com/watch?v=20E4xv…

.Anteris Technologies shares data from the DurAVR THV FIH study. It shows sustained haemodynamic performance at 1 year. Presented by Susheel Kodali, MD with simultaneous publication at #EuroPCR. #TAVR #TAVI Sponsored post by Anteris Technologies

New biomimetic #TAVR valve linked to strong performance after 1 year Anteris Technologies João Cavalcante Chris Meduri, MD MPH Pankaj Garg EuroIntervention Susheel Kodali, MD Columbia Valve Center Columbia Medicine #DurAVR #cardiology #cardiotwitter ow.ly/kNc150Ow1ol

#Anteristech announces powerful new data from the DurAVR™ THV FIH Study demonstrating sustained haemodynamic performance at 1 year in 12 patients. #TAVR $AVR #TAVI #cardiology #AnterisTech Read Full Announcement: links.anteristech.com/3MVmdNf

.Chris Meduri, MD MPH presents the latest data from the DurAVR™ THV FIH Study demonstrating sustained haemodynamic performance at 1 year. #TAVR $AVR #TAVI #cardiology #AnterisTech #TVT2023

Great article by Michael O'Riordan on the impact/importance of no-implant shunts. RF allows for a durable septectomy.

An incredible result for this patient from a remarkable team. Congrats Anita Asgar and team! More to come! Janar Sathananthan João Cavalcante RTHahnMD thomas modine Dr. Nicolas M Van Mieghem Andreas Rück Dr. Gilbert Tang Thomas Waggoner Gorav Ailawadi Stephanie Sellers Azeem Latib vinayak bapat

Incredibly work by Montefiore Heart and proud of Anteris Technologies to announce the first patients enrolled in the DurAVR US EFS study. The first US patients treated with a biomimetic valve! Incredible results, small annuli with mean EOA of 2.2 and mean gradient of 4 acutely! Azeem Latib

Congratulations to Thomas Waggoner and his team on 2 outstanding DurAVR cases this week. Seeing your team do a pristine case in only 20 minutes is a testament to your whole program! Look forward to many more soon. Anteris Technologies

Congratulations to the incredible team Cleveland Clinic for 3 great DurAVR cases last week. All with excellent results! Always great seeing good friends Rishi Puri Amar Krishnaswamy Samir Kapadia and super fellow Travis Howard ! Look forward to more soon! #tavr PCRonline 🫀 TCTMD

It is with great pleasure to announce the completion of the DurAVR EFS enrollment! Thank you U-M Health Frankel CVC. This first-in-class biomimetic valve exceeded already remarkable prior results. More details next week in San Fran TCTMD and in London as a LBCT PCRonline 🫀. Anteris Technologies #tavr

DurAVR US EFS results presented TCTMD by Azeem Latib today In small annuli patients (mean 22.2): ✔️ safe, easy to use ✔️ no pacemakers ✔️ 93% no/trace, 7% mild PVL 🎯mean EOA 2.36 🎯MPG 7.8 🎯DVI 0.71 This groundbreaking, first biomimetic valve will change AS treatment

An insight into why aortic flow is becoming a novel therapeutic target. In collaboration with world experts in aortic physiology. natureNews Nature Reviews Cardiology @Nature #WhyCMR #4DFlowCMR Thanks ALL (Chris Meduri, MD MPH) and legendary Michael Markl! Paper ⬇️ nature.com/articles/s4156…

Great week at TCT with incredible data being presented by Anteris demonstrating superior MPG's ,superior EOA's and superior DVI's to current therapies. A huge thanks to our team,Physicians and patients. We are moving the conversation forward ! #proudtobeanteris #DurAVR

Visionary work led by Pankaj Garg looking at the impact of aortic flow abnormalities on CV disease. Likely an important feature in future AVR development. João Cavalcante RTHahnMD Janar Sathananthan Stephanie Sellers

#PCRLV: Azeem Latib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (Anteris Technologies). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance

⭐️ FIH & EFS data on DurAVR just presented by Azeem Latib #PCRLV 🎯Balloon-expandable 🎯Commissure-alignment 🎯Long coaptation length 🎯EXCELLENT Hemodynamics Chris Meduri, MD MPH Anteris Technologies Montefiore Heart

Insights of FIH and EFS use of DurAVR (Anteris Technologies) a single-leaflet design biomimetic valve are presented at #EuroPCR by Chris Meduri

#NYValves2024 Cardiovascular Research Foundation João Cavalcante presents the First in Human #DurAVR results ❓Why another BEV? Unique Flow displacement characteristics & promising early imaging data 🔹20 point biomimetic improvement in LV mass LV remodeling & restoration of laminar flow hence Ao